• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of pathology and translational medicine

    Journal of pathology and translational medicine

    JournalISSN 2383-7837eISSN 2383-7845中科院 医学 4区

    年发文量

    研究主题

    论文(909)

    排序
    1Comment on “what’s New in Digital and Computational Pathology 2026: Advances in Adoption, Standards, AI Technologies, and Clinical Integration”
    Muhammad Abu Bakar Moin
    2026
    引用
    AI阅读
    加入学术空间
    2Intracranial Malignant Peripheral Nerve Sheath Tumor with Myxoid Morphology Evolving Across Recurrences: a Case Report
    Frantisek Vana,Petra Pokorna,Petr Pospisil,Zdenek Mackerle,Marketa Hermanova, Iva Staniczkova Zambo,Martin Barak, Robin Jugas,Radim Jancalek,Ondrej Slaby,Michal Hendrych

    A malignant peripheral nerve sheath tumor (MPNST) is a rare, aggressive spindle-cell sarcoma that exceptionally occurs intracranially. Herein, we report a case of intracranial spindle-cell neoplasm with abundant myxoid stroma. The immunophenotype of the primary tumor did not align with any known peripheral nerve sheath tumor and the lesion did not correspond to any methylation category defined by the Heidelberg classifier with a sufficiently high classification score, although MPNST was the highest-scoring category. Over the course of repeated recurrences, the tumor acquired increased cellularity, mitotic activity and loss of H3K27me3 expression. Subsequent methylation profiling supported a diagnosis of MPNST. The tumor harbored a gain-of-function variant in NRAS p.Gly13Arg and TP53 p.Arg273Cys from the initial tumor onwards, consistent with previous reports describing activation of Ras/mitogen-activated protein kinase as an early event in MPNST tumorigenesis. These findings illustrate the diagnostic complexity of rare intracranial sarcomas with myxoid morphology and suggest that some may represent early MPNST.

    2026
    引用
    AI阅读
    加入学术空间
    3Concordance of Flow Cytometric E6/E7 Mrna Detection with Human Papillomavirus DNA Testing and Cervical Cytology in a Cervical Cancer Screening Cohort
    Dat Quoc Ngo, Trang Kieu Ha, Mi Ngoc Thi Tran, Anh Mai Thi Nguyen, Truong Nhat Trinh,Thien Thanh Ly,Linh Ngoc Khanh Nguyen,Thu Dang Anh Phan

    Background: Overexpression of viral oncogenes E6 and E7 of high-risk (HR)–human papillomavirus (HPV) plays a key role in the progression to cervical intraepithelial neoplasia (CIN) and cancer. Detection of E6/E7 mRNA may help distinguish between transient and transforming infections, thus improving cervical cancer screening accuracy. This study aimed to evaluate the association of E6/E7 mRNA expression with HR-HPV infection, cervical cytology, and histologically confirmed cervical lesions and to compare its agreement with HPV DNA testing and cytology. Methods: A total of 526 women undergoing cervical cancer screening between January 2023 and May 2025 were enrolled. E6/E7 mRNA expression was assessed using flow cytometry with the HPV OncoTect 3Dx E6/E7 mRNA assay and compared with HR-HPV DNA testing, cervical cytology, and available histopathologic findings from biopsy specimens. Results: Among 526 samples, eight (1.5%) tested positive for E6/E7 mRNA, compared to 30 (5.7%) HR-HPV DNA–positive and 17 (3.2%) abnormal cytology results. Median E6/E7 mRNA expression was higher in HR-HPV– positive cases and in cytologically abnormal cases. Almost perfect agreement was observed between E6/E7 mRNA results, HR-HPV DNA testing, and cytology. Histopathologic follow-up was available for nine women with cytological abnormalities ≥low-grade squamous intraepithelial lesion, including four CIN2 and five CIN1 cases. E6/E7 mRNA expression was markedly elevated in one CIN2 case associated with HPV16 infection (37.51%), while two CIN1 cases demonstrated high mRNA expression despite negative HPV DNA results. Conclusions: Flow-cytometric E6/E7 mRNA detection showed high overall agreement with HPV DNA testing and cytology in this screening cohort. Larger prospective studies with comprehensive histologic follow-up are needed to determine its clinical utility.

    2026
    引用
    AI阅读
    加入学术空间
    4Targeted Next-Generation Sequencing–based Mutational Signature Analysis in Endometrial Cancer: Utility and Limitations Across Molecular Subtypes
    Uijin Kim,Ahwon Lee,Keun Ho Lee,Sung Jong Lee,Sook Hee Hong,Donghyuk Lee,Jun Kang,Miseon Lee

    Background: Molecular subtype classification is essential for staging endometrial cancer, planning adjuvant treatments, and stratifying prognosis. However, the correlation between mutational signature analysis using tumor-only targeted next-generation sequencing (NGS) data and molecular subtypes, as well as the interpretive value at the individual case level, remains inadequately characterized. Methods: We performed mutational signature analysis on tumor-only targeted NGS data from 72 endometrial cancer cases using the SATS R package. Molecular classification into four subtypes (POLE-mutated, mismatch repair deficient [MMRd], TP53-mutant, and no specific molecular profile [NSMP]) was established through a standard stepwise algorithm that integrated NGS and immunohistochemistry. Results: Out of the 72 endometrial cancers, 12 were classified as POLE-mutated, 10 as MMRd, six as TP53-mutant, and 44 as NSMP. All POLE-mutated tumors exhibited POLE-associated signatures (SBS10a/SBS10b), including cases with non-hotspot POLE exonuclease variants and tumor mutation burdens below the conventional ultramutation threshold. MMRd-associated signatures showed a broader distribution across molecular subtypes; while the summed MMRd-associated signatures were typically higher in MMRd tumors, low-level contributions were also noted in subsets of NSMP and TP53-mutant tumors. Within the POLE-mutated group, MMRd-associated signatures were more pronounced in cases displaying subclonal MMR protein loss as determined by immunohistochemistry. Conclusions: In this small, clinically selected cohort, targeted NGS-based mutational signatures provided exploratory, complementary information regarding POLE-associated mutagenesis and mixed MMR-related patterns. Overlapping signature distributions, dependence on the analytical pipeline, and the use of tumor-only targeted sequencing limit case-level interpretation. Mutational signature analysis should be interpreted in conjunction with established molecular tests and should not be used as a stand-alone classifier.

    2026
    引用
    AI阅读
    加入学术空间
    5Corrigendum: Current Status and Future Perspectives of Liquid Biopsy in Non-Small Cell Lung Cancer
    Sunhee Chang,Jae Young Hur,Yoon-La Choi, Chang Hun Lee,Wan Seop Kim
    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 909 篇论文

    高被引作者

    作者引用发文
    Chan Kwon Jung62624
    Hye Seung Lee52620
    So Yeon Park43819
    Chan-Sik Park4348
    Jin Roh4256
    So-Woon Kim4205
    Jeong Mo Bae37118
    Yoon-La Choi36212
    Soonwon Hong33919
    Joung Ho Han33119

    高产作者

    作者引用发文
    Chan Kwon Jung62624
    Hye Seung Lee52620
    Soonwon Hong33919
    So Yeon Park43819
    Joung Ho Han33119
    Kyung-Ja Cho32019
    Na Rae Kim12218
    Jeong Mo Bae37118
    Kim Wan Seop16317
    Gyeong Hoon Kang32416

    相关期刊

    Cytopathology
    Pathology International
    Seminars in diagnostic pathology
    Virchows Archiv. A, Pathological anatomy and histology
    Advances in anatomic pathology
    Applied immunohistochemistry & molecular morphology : AIMM
    Endocrine Pathology
    Surgical pathology clinics
    Pathologica
    Virchows Archiv